Search Results - "Gimbergues, P."

Surgery in reference centers improves survival of sarcoma patients: a nationwide study by Blay, J.-Y., Honoré, C., Stoeckle, E., Meeus, P., Jafari, M., Gouin, F., Anract, P., Ferron, G., Rochwerger, A., Ropars, M., Carrere, S., Marchal, F., Sirveaux, F., Di Marco, A., Le Nail, L.R., Guiramand, J., Vaz, G., Machiavello, J.-C., Marco, O., Causeret, S., Gimbergues, P., Fiorenza, F., Chaigneau, L., Guillemin, F., Guilloit, J.-M., Dujardin, F., Spano, J.-P., Ruzic, J.-C., Michot, A., Soibinet, P., Bompas, E., Chevreau, C., Duffaud, F., Rios, M., Perrin, C., Firmin, N., Bertucci, F., Le Pechoux, C., Le Loarer, F., Collard, O., Karanian-Philippe, M., Brahmi, M., Dufresne, A., Dupré, A., Ducimetière, F., Giraud, A., Pérol, D., Toulmonde, M., Ray-Coquard, I., Italiano, A., Le Cesne, A., Penel, N., Bonvalot, S.

“…NETSARC (netsarc.org) is a network of 26 sarcoma reference centers with specialized multidisciplinary tumor boards (MDTB) aiming to improve the outcome of…”
Get full text

Survival Benefit of the Surgical Management of Retroperitoneal Sarcoma in a Reference Center: A Nationwide Study of the French Sarcoma Group from the NetSarc Database by Bonvalot, S., Gaignard, E., Stoeckle, E., Meeus, P., Decanter, G., Carrere, S., Honore, C., Delhorme, J. B., Fau, M., Tzanis, D., Causeret, S., Gimbergues, P., Guillois, J. M., Meunier, B., Le Cesne, A., Ducimetiere, F., Toulmonde, M., Blay, J. Y.

“…Background Guidelines recommend that retroperitoneal sarcoma (RPS) be managed in a reference sarcoma center (RSC), but the benefit remains to be demonstrated…”
Get full text

Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study by Classe, Jean-Marc, Loaec, Cecile, Gimbergues, P., Alran, S., de Lara, C. Tunon, Dupre, P. F., Rouzier, Roman, Faure, C., Paillocher, N., Chauvet, M. P., Houvenaeghel, G., Gutowski, M., De Blay, P., Verhaeghe, J. L., Barranger, E., Lefebvre, C., Ngo, C., Ferron, G., Palpacuer, C., Campion, L.

“…Purpose GANEA2 study was designed to assess accuracy and safety of sentinel lymph node (SLN) after neo-adjuvant chemotherapy (NAC) in breast cancer patients…”
Get full text

Surgery in reference centers improves survival of sarcoma patients: a nationwide study by Blay, J -Y, Honoré, C, Stoeckle, E, Meeus, P, Jafari, M, Gouin, F, Anract, P, Ferron, G, Rochwerger, A, Ropars, M, Carrere, S, Marchal, F, Sirveaux, F, Di Marco, A, Le Nail, L R, Guiramand, J, Vaz, G, Machiavello, J -C, Marco, O, Causeret, S, Gimbergues, P, Fiorenza, F, Chaigneau, L, Guillemin, F, Guilloit, J -M, Dujardin, F, Spano, J -P, Ruzic, J -C, Michot, A, Soibinet, P, Bompas, E, Chevreau, C, Duffaud, F, Rios, M, Perrin, C, Firmin, N, Bertucci, F, Le Pechoux, C, Le Loarer, F, Collard, O, Karanian-Philippe, M, Brahmi, M, Dufresne, A, Dupré, A, Ducimetière, F, Giraud, A, Pérol, D, Toulmonde, M, Ray-Coquard, I, Italiano, A, Le Cesne, A, Penel, N, Bonvalot, S

Get full text

Axillary lymph node micrometastases decrease triple-negative early breast cancer survival by Houvenaeghel, G, Sabatier, R, Reyal, F, Classe, J M, Giard, S, Charitansky, H, Rouzier, R, Faure, C, Garbay, J R, Daraï, E, Hudry, D, Gimbergues, P, Villet, R, Lambaudie, E

“…Background: Triple-negative breast cancers (TNBCs) are the most deadly form of breast cancer (BC) subtypes. Axillary lymph node involvement (ALNI) has been…”
Get full text

Lymphovascular invasion has a significant prognostic impact in patients with early breast cancer, results from a large, national, multicenter, retrospective cohort study by Houvenaeghel, G., Cohen, M., Classe, J.M., Reyal, F., Mazouni, C., Chopin, N., Martinez, A., Daraï, E., Coutant, C., Colombo, P.E., Gimbergues, P., Chauvet, M.P., Azuar, A.S., Rouzier, R., Tunon de Lara, C., Muracciole, X., Agostini, A., Bannier, M., Charaffe Jauffret, E., De Nonneville, A., Goncalves, A.

“…We determined the prognostic impact of lymphovascular invasion (LVI) in a large, national, multicenter, retrospective cohort of patients with early breast…”
Get full text

Impact of completion axillary lymph node dissection in patients with breast cancer and isolated tumour cells or micrometastases in sentinel nodes by Houvenaeghel, G, Boher, J.M, Reyal, F, Cohen, M, Garbay, J.R, Classe, J.M, Rouzier, R, Giard, S, Faure, C, Charitansky, H, Tunon de Lara, C, Daraï, E, Hudry, D, Azuar, P, Gimbergues, P, Villet, R, Sfumato, P, Lambaudie, E

“…Abstract Background Omission of completion axillary lymph node dissection (ALND) is a standard practice in patients with breast cancer (BC) and negative…”
Get full text

Characteristics and clinical outcome of T1 breast cancer: a multicenter retrospective cohort study by Houvenaeghel, G., Goncalves, A., Classe, J.M., Garbay, J.R., Giard, S., Charytensky, H., Cohen, M., Belichard, C., Faure, C., Uzan, S., Hudry, D., Azuar, P., Villet, R., Gimbergues, P., Tunon de Lara, C., Martino, M., Lambaudie, E., Coutant, C., Dravet, F., Chauvet, M.P., Chéreau Ewald, E., Penault-Llorca, F., Esterni, B.

“…A subgroup of T1N0M0 breast cancer (BC) carries a high potential of relapse, and thus may require adjuvant systemic therapy (AST). Retrospective analysis of…”
Get full text

Mastectomy with immediate breast reconstruction after neoadjuvant chemotherapy and radiation therapy. A new option for patients with operable invasive breast cancer. Results of a 20 years single institution study by Monrigal, E, Dauplat, J, Gimbergues, P, Le Bouedec, G, Peyronie, M, Achard, J.L, Chollet, P, Mouret-Reynier, M.A, Nabholtz, J.M, Pomel, C

“…Abstract Purpose To evaluate the feasability of immediate breast reconstruction (IBR) following mastectomy after neoadjuvant chemotherapy (NACT) and radiation…”
Get full text

Impact of hormone receptor status in HER2+ early breast cancer: A paradigm shift in the trastuzumab era by De Nonneville, A., Gonçalves, A., Boher, J.-M., Cohen, M., Reyal, F., Classe, J.-M., Giard, S., Colombo, P.-E., Muracciol, X., Darai, E., Jouve, E., Mazouni, C., Gimbergues, P., Azuar, A.-S., Barranger, E., Rouzier, R., Villet, R., Chopin, N., Lambaudie, E., Houvenaeghel, G.

Get full text

Benefit of adjuvant systemic therapies in HR+ HER2- pT1ab node-negative breast carcinomas by De Nonneville, A., Gonçalves, A., Boher, J.-M., Classe, J.-M., Cohen, M., Colombo, P.-E., Reyal, F., Chauvet, M.-P., Jouve, E., Darai, E., Blache, G., Coutant, C., Gimbergues, P., Mazouni, C., Rouzier, R., Villet, R., Crochet, P., Azuar, A.-S., Lambaudie, E., Houvenaeghel, G.

Get full text

Benefit of adjuvant chemotherapy in hormone receptor-positive, HER2-negative, invasive lobular carcinoma of the breast by De Nonneville, A., Jauffret, C., Gonçalves, A., Classe, J.-M., Cohen, M., Reyal, F., Mazouni, C., Chauvet, M.-P., Chopin, N., Colombo, P.-E., Jouve, E., Darai, E., Rouzier, R., Coutant, C., Gimbergues, P., Azuar, A.-S., Tunon de Lara, C., Lambaudie, E., Houvenaeghel, G.

Get full text

Lack of prognostic impact of sentinel node micro-metastases in endocrine receptor-positive early breast cancer: results from a large multicenter cohort by Houvenaeghel, G., de Nonneville, A., Cohen, M., Chopin, N., Coutant, C., Reyal, F., Mazouni, C., Gimbergues, P., Azuar, A.-S., Chauvet, M.-P., Classe, J.-M., Daraï, E., Martinez, A., Rouzier, R., de Lara, C.T., Lambaudie, E., Barrou, J., Goncalves, A.

“…Prognostic impact of lymph node micro-metastases (pN1mi) has been discordantly reported in the literature. The need to clarify this point for decision-making…”
Get full text

Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy Is Accurate in Breast Cancer Patients with a Clinically Negative Axillary Nodal Status at Presentation by Gimbergues, P., Abrial, C., Durando, X., Bouedec, G. Le, Cachin, F., Penault-Llorca, F., Mouret-Reynier, M. A., Kwiatkowski, F., Maublant, J., Tchirkov, A., Dauplat, J.

“…Background In breast cancer, neoadjuvant chemotherapy (NAC) is widely used in order to enable a conservative surgery. In patients treated with NAC, the use of…”
Get full text

Feasibility of sentinel lymph node biopsy in multiple unilateral synchronous breast cancer: results of a French prospective multi-institutional study (IGASSU 0502) by Giard, S., Chauvet, M.-P., Penel, N., Mignotte, H., Martel, P., Tunon de Lara, C., Gimbergues, P., Dessogne, P., Classe, J.-M., Fondrinier, E., Marmousez, T.

“…To prospectively determine the feasibility of sentinel lymph node biopsy (SLNB) in preoperatively diagnosed multiple unilateral synchronous invasive breast…”
Get full text

Cost comparison of axillary sentinel lymph node detection and axillary lymphadenectomy in early breast cancer. A national study based on a prospective multi-institutional series of 985 patients ‘on behalf of the Group of Surgeons from the French Unicancer Federation’ by Classe, J.M., Baffert, S., Sigal-Zafrani, B., Fall, M., Rousseau, C., Alran, S., Rouanet, P., Belichard, C., Mignotte, H., Ferron, G., Marchal, F., Giard, S., Tunon de Lara, C., Le Bouedec, G., Cuisenier, J., Werner, R., Raoust, I., Rodier, J.-F., Laki, F., Colombo, P.-E., Lasry, S., Faure, C., Charitansky, H., Olivier, J.-B., Chauvet, M.-P., Bussières, E., Gimbergues, P., Flipo, B., Houvenaeghel, G., Dravet, F., Livartowski, A.

“…Our objective was to assess the global cost of the sentinel lymph node detection [axillary sentinel lymph node detection (ASLND)] compared with standard…”
Get full text

Intraoperative Imprint Cytology Examination of Sentinel Lymph Nodes After Neoadjuvant Chemotherapy in Breast Cancer Patients by Gimbergues, P., Dauplat, M. M., Durando, X., Abrial, C., Le Bouedec, G., Mouret-Reynier, M. A., Cachin, F., Kwiatkowski, F., Tchirkov, Andrei, Dauplat, J., Penault-Llorca, F.

“…Background Intraoperative imprint cytology (IC) is one of several accurate, proven methods to detect tumor cells in sentinel lymph nodes (SLN) from patients…”
Get full text

Salvage concomitant chemoradiation therapy for non-metastatic inflammatory breast cancer after chemotherapy failure by Bellière-Calandry, A, Benoît, C, Dubois, S, Moreau, J, Achard, J-L, Loos, G, Mouret-Reynier, M-A, Van Praagh-Doreau, I, Gimbergues, P, Lebouedec, G, Pomel, C, Lapeyre, M

“…To evaluate the surgical possibility following concomitant chemoradiotherapy for inflammatory breast cancer, after unsucessful neoadjuvant chemotherapy. The…”
Get full text

Clinicopathological Factors and Nomograms Predicting Nonsentinel Lymph Node Metastases After Neoadjuvant Chemotherapy in Breast Cancer Patients by Gimbergues, P., Abrial, C., Durando, X., Le Bouedec, G., Cachin, F., Penault-Llorca, F., Mouret-Reynier, M. A., Kwiatkowski, F., Maublant, J., Tchirkov, A., Dauplat, J.

“…Background Studies have demonstrated the feasibility and accuracy of sentinel lymph node (SLN) biopsy after neoadjuvant chemotherapy (NAC) in breast cancer…”
Get full text

Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category by Gimbergues, P, Dauplat, M.M, Cayre, A, Durando, X, Le Bouedec, G, Finat-Duclos, F, Portefaix, G, Kwiatkowski, F, Dauplat, J, Penault-Llorca, F, Tchirkov, A

“…Abstract Aims To evaluate the clinical significance of tumour metastases detected using real-time reverse transcription-PCR (RT–PCR) in sentinel lymph nodes…”
Get full text